Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | GMNN | O75496 | 1/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.60 |
| ▸ | PPARG | P37231 | 7/20 | 0.60 |
| ▸ | PPARD | Q03181 | 7/20 | 0.60 |
| ▸ | PPARA | Q07869 | 7/20 | 0.60 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624892 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL1603644 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL28388081 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL28905473 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL3135887 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL9262447 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL9185714 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL8865660 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL1527381 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB | |
| SCHEMBL11465686 | 1.00 | HSD17B10 (0.67) | HSD17B10MAPTGMNNTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0344733-A2 | Novel antioxidant-peroxides and their use | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1989-12-06 | — | — | EP | claimed |
| EP-0027439-A1 | Method for stabilising vinylchloride polymer resins | M & T CHEMICALS, INC. (US) | 1981-04-22 | — | — | EP | claimed |
| JP-6287588-A | — | — | None | — | — | JP | disclosed |
| JP-6287589-A | — | — | None | — | — | JP | disclosed |
| US-8815478-B2 | Colored curable composition, resist liquid, ink for inkjet printing, color filter, method of producing color filter, solid-state image sensor, liquid crystal display, organic EL display, image display device and colorant compound | FUJIFILM CORPORATION (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20120264039-A1 | COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND | FUJIFILM CORPORATION (JP) | 2012-10-18 | — | — | US | disclosed |
| US-5516856-A | IMPROVED PROCESS FOR THE MODIFICATION OF THE MOLECULAR CHAIN OF A POLYMER | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1996-05-14 | — | — | US | disclosed |
| US-5391564-A | E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents | SANKYO COMPANY, LIMITED (JP) | 1995-02-21 | — | — | US | disclosed |
| JP-H06287589-A | WATER-SOLUBLE LUBRICATING RUST-PREVENTIVE OIL FOR PLASTIC WORKING | NIPPON OIL & FATS CO LTD | 1994-10-11 | — | — | JP | disclosed |
| JP-H06287588-A | WATER-SOLUBLE CUTTING OIL | NIPPON OIL & FATS CO LTD | 1994-10-11 | — | — | JP | disclosed |
| US-5352689-A | Rhizoxin derivatives and their use as anti-tumor agents | SANKYO COMPANY, LIMITED (JP) | 1994-10-04 | — | — | US | disclosed |
| EP-0350315-B1 | RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS | SANKYO COMPANY LIMITED (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0166509-B1 | PHENOL DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-05-13 | — | — | EP | disclosed |
| US-5051531-A | As polymerization catalysts and for crosslinking | ATOCHEM NORTH AMERICA, INC. (US) | 1991-09-24 | — | — | US | disclosed |
| EP-0399278-A2 | Heterocyclic amidine derivatives | BASF Aktiengesellschaft (DE) | 1990-11-28 | — | — | EP | disclosed |
| EP-0350315-A1 | Rhizoxin derivates and their use as anti-tumor agents | SANKYO COMPANY LIMITED (JP) | 1990-01-10 | — | — | EP | disclosed |
| EP-0344733-A2 | Novel antioxidant-peroxides and their use | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1989-12-06 | — | — | EP | disclosed |
| US-4835273-A | LIGHT AND HEAT STABILIZERS FOR POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1989-05-30 | — | — | US | disclosed |
| US-4833135-A | Antioestrogenic phenol derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-23 | — | — | US | disclosed |
| EP-0166509-A1 | Phenol derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264039-A1 | COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND | CDYL, RET, NLRP1 | HSD17B10 3361/4885MAPT 283/4885GMNN 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.